Wednesday, September 14, 2016
Greenwich, CT (September 14, 2016) – The Greenwich Hospital Foundation announced today that Stephen Corman of Stamford, CT has committed to a gift of $1 million to establish the Stephen Corman Prostate Cancer Early Detection Initiative. The goal of the initiative is to expand access to the highest standard of prostate cancer care to the community while maintaining the convenience and comfort of being close to home.
The initiative will fund the purchase of a 3-D imaging navigation system that allows urologists to progress from broad, systematic biopsies to biopsies that are mapped, targeted and tracked. The increased accuracy of this MRI/ultrasound fusion device promotes active surveillance in patients with less aggressive cancers, allowing them to prevent or postpone invasive treatments that often lead to negative side effects such as incontinence or impotence.
“This impressive piece of equipment will be the first of its kind in Fairfield County, giving our patients local access to cutting-edge technology for the evaluation, diagnosis, and treatment of prostate cancer,” said Norman G. Roth, president of Greenwich Hospital.
In addition to the technology and training essential to the initiative, Corman’s gift will provide support for prostate cancer research in coordination with Yale School of Medicine. These combined efforts ensure that patients have access to the very best in early detection and management of prostate cancer.
A retired employee of IBM Corporation, Corman is a long-time volunteer and donor to Greenwich Hospital. This year, he volunteered over 600 hours at Greenwich Hospital and leads a prostate cancer education forum and support group.
“I consider myself a patient advocate who truly wants what is best for the patient,” said Corman. He was inspired to make this gift as a result of his personal experience with prostate cancer and gratitude for the care he received at Smilow Cancer Hospital's Greenwich Hospital Campus.
“At Greenwich Hospital, patients are our focus and this generous gift will support both scientific research and its direct impact on the care we provide,” said Spike Lipschutz, MD, senior vice president of medical services and chief medical officer. “In medicine, any time we can obtain critical information with less invasion of our patients is a critical step toward improving outcomes and providing a better personal experience. We are excited to be part of this ongoing process to maximize high quality safe care.”